Switch to:

Arena Pharmaceuticals Interest Expense

: $-5.2 Mil (TTM As of Jun. 2019)
View and export this data going back to 2000. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Arena Pharmaceuticals's interest expense for the three months ended in Jun. 2019 was $ -1.2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2019 was $-5.2 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Arena Pharmaceuticals's Operating Income for the three months ended in Jun. 2019 was $ -68.6 Mil. Arena Pharmaceuticals's Interest Expense for the three months ended in Jun. 2019 was $ -1.2 Mil. Arena Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Arena Pharmaceuticals Interest Expense Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arena Pharmaceuticals Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Interest Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.92 -6.83 -6.51 -6.12 -5.70

Arena Pharmaceuticals Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Interest Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.45 -1.42 -1.35 -1.24 -1.22

Arena Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2019 was -1.423 (Sep. 2018 ) + -1.351 (Dec. 2018 ) + -1.241 (Mar. 2019 ) + -1.222 (Jun. 2019 ) = $-5.2 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arena Pharmaceuticals  (NAS:ARNA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Arena Pharmaceuticals's Interest Expense for the three months ended in Jun. 2019 was $-1.2 Mil. Its Operating Income for the three months ended in Jun. 2019 was $-68.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2019 was $47.6 Mil.

Arena Pharmaceuticals's Interest Coverage for the quarter that ended in Jun. 2019 is calculated as

Arena Pharmaceuticals did not have earnings to cover the interest expense.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies interest coverage is at least 5. Arena Pharmaceuticals Inc has enough cash to cover all of its debt. Its financial situation is stable.


Arena Pharmaceuticals Interest Expense Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK